STO Equity Snapshot
IBT-B Weekly Equity Report
Infant Bacterial Therapeutics AB (publ)
What the company does
Infant Bacterial Therapeutics AB (publ) operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, which has completed Phase III clinical studies to prevent necrotizing enterocolitis, as well as to improve feeding tolerance in premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe birth abnormality in infants. In addition, its drug candidates include IBP-1118 to prevent retinopathy of prematurity that causes blindness in premature babies; and IBP-1122, indicated to eliminate …
What the weekly tape is saying
IBT-B closed the latest completed week at 61.00 SEK. The 4-week return is 7.0% and the 12-week return is 26.6%. Trend Signal is active, Market Dynamics is 1.14. Setup signature: Deep recovery attempt with a 56/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 51.70 SEK
- Vs Trend Line
- 18.0%
- Fair Value
- 66.03 SEK
- Vs Fair Value
- -7.6%
- 52W High
- 84.30 SEK
- 52W Low
- 43.25 SEK
- Drawdown
- -27.6%
- Range Position
- 43.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 4 weeks
- 52W Active Weeks
- 25
- 52W Active Breadth
- 48.1%
- Sector Scope
- SE Healthcare
- Sector Rank
- 27 of 158
- Sector Percentile
- 83.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 22 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 13 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.14
- 4W MD Change
- 14.4%
- Relative Strength
- 1.66
- 4W RS Change
- 137.8%
- Expectation
- Negative
- Probability
- 44.54%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 42.7K
- 13W Average
- 45.4K
- 52W Average
- 46.7K
- Vs 13W
- 0.9x
- Vs 52W
- 0.9x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.4%
- 52W Volatility
- 6.8%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 5.2% / -4.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 781.3M
Opportunity signals
- Trend Signal is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 61.00 SEK | 6.3% | 51.70 SEK | 66.03 SEK | 1.14 | 1.66 | 42.7K | On |
| 5 Jun 2026 | 57.40 SEK | 2.9% | 51.34 SEK | 65.93 SEK | 1.14 | -4.74 | 34.1K | On |
| 29 May 2026 | 55.80 SEK | 0.4% | 51.48 SEK | 65.85 SEK | 1.15 | -8.45 | 60.5K | On |
| 22 May 2026 | 55.60 SEK | -2.5% | 51.58 SEK | 65.77 SEK | 1.05 | -9.49 | 66.9K | On |
| 15 May 2026 | 57.00 SEK | 5.0% | 51.74 SEK | 65.69 SEK | 1.00 | -4.40 | 40.0K | Off |
| 8 May 2026 | 54.30 SEK | 0.7% | 51.94 SEK | 65.60 SEK | 0.85 | -10.34 | 149.6K | Off |
| 1 May 2026 | 53.90 SEK | -2.0% | 52.22 SEK | 65.55 SEK | 0.49 | -11.23 | 15.1K | Off |
| 24 Apr 2026 | 55.00 SEK | 2.2% | 52.64 SEK | 65.52 SEK | 0.45 | -11.09 | 23.2K | Off |
| 17 Apr 2026 | 53.80 SEK | 8.1% | 53.16 SEK | 65.49 SEK | 0.27 | -15.59 | 39.9K | Off |
| 10 Apr 2026 | 49.75 SEK | 0.7% | 53.76 SEK | 65.45 SEK | 0.07 | -20.48 | 11.0K | Off |
| 3 Apr 2026 | 49.40 SEK | -0.9% | 54.56 SEK | 65.45 SEK | 0.16 | -17.86 | 70.0K | Off |
| 27 Mar 2026 | 49.85 SEK | 3.4% | 55.47 SEK | 65.45 SEK | 0.09 | -14.42 | 14.6K | Off |
| 20 Mar 2026 | 48.20 SEK | -3.5% | 55.97 SEK | 65.43 SEK | 0.17 | -17.06 | 23.0K | Off |
| 13 Mar 2026 | 49.95 SEK | -0.3% | 56.13 SEK | 65.43 SEK | 0.27 | -18.09 | 21.7K | Off |